PART I COMPANY OVERVIEW We are a leading provider of technology solutions to improve therapeutics manufacturing. We focus on impacting the manufacturing process by using o ur proprietary CodeEvolver directed evolution technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. Enzymes are naturally occurring biological molecules critical to almost all biochemical reactions. They can be precisely engineered and optimized for ...
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-11 | 2025-12-31 | 0001200375-26-000006 | EDGAR | 69K words |
| 2025-02-27 | 2024-12-31 | 0001200375-25-000003 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001200375-24-000009 | EDGAR | — |
| 2023-02-27 | 2022-12-31 | 0001200375-23-000012 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001200375-22-000010 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001200375-21-000021 | EDGAR | — |
| 2020-02-28 | 2019-12-31 | 0001200375-20-000008 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001200375-19-000005 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001200375-18-000009 | EDGAR | — |
| 2017-03-09 | 2016-12-31 | 0001200375-17-000007 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001200375-25-000016 | EDGAR | 39K words |
| 2025-08-13 | 2025-06-30 | 0001200375-25-000012 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001200375-25-000006 | EDGAR | — |
| 2024-10-31 | 2024-09-30 | 0001200375-24-000027 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001200375-24-000022 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0001200375-24-000015 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001200375-23-000033 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001200375-23-000029 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001200375-23-000019 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001200375-22-000039 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0001200375-22-000032 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001200375-22-000018 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-11 | 0001193125-26-102146 | EDGAR | 4K words |
| 2025-11-06 | 0001193125-25-269716 | EDGAR | — |
| 2025-08-13 | 0001193125-25-179817 | EDGAR | — |
| 2025-06-11 | 0001193125-25-139123 | EDGAR | — |
| 2025-05-14 | 0001193125-25-119847 | EDGAR | — |
| 2025-04-09 | 0001193125-25-076926 | EDGAR | — |
| 2025-03-31 | 0001193125-25-067978 | EDGAR | — |
| 2025-02-27 | 0001193125-25-039264 | EDGAR | — |
| 2025-01-16 | 0001193125-25-007775 | EDGAR | — |
| 2024-11-12 | 0001193125-24-255904 | EDGAR | — |
288 total filings indexed. 256 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001200375 |
| Ticker | CDXS |
| Exchange | Nasdaq |
| SIC | 2860: Industrial Organic Chemicals |
| Incorporated | DE |
| Website | https://www.codexis.com |
| Listed | 2010-04-22 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report